Best Hospitals for Prostate cancer treatment in Lithuania 2026

Prostate cancer treatment in Lithuania primarily includes radical prostatectomy, radiation therapy, and systemic treatments like hormone therapy. Specialist centers in Vilnius and Kaunas utilize laparoscopic and robotic-assisted techniques for localized cases. Advanced protocols follow European standards to ensure high-precision care and rapid recovery.

• Surgical interventions: Surgeons perform radical prostatectomy using laparoscopic or robotic-assisted methods for precision.
• Radiation therapies: Options include external beam radiation and brachytherapy with radioactive source placement.
• Systemic treatments: Advanced cases receive androgen deprivation therapy, chemotherapy, or targeted immunotherapy drugs.
• Early detection: A national program provides PSA testing for men aged 50 to 69.

Bookimed Expert Insight: While many patients focus on surgery, the Medical Diagnostic and Treatment Center in Vilnius emphasizes integrated rehabilitation. This clinic treats over 48,000 patients annually and maintains Joint Commission International (JCI) accreditation. Their approach focuses on rapid functional recovery to help international patients return home sooner after complex urological procedures.

Patient Consensus: Patients emphasize that surgeon experience is vital for avoiding long-term side effects like incontinence. Many recommend getting a second opinion from both a urologist and an oncologist before starting treatment.

Lithuania reports a 94.3% five-year relative survival rate for prostate cancer. This is one of the highest rates in Europe. Early detection programs and increased PSA testing drive these outcomes. Survival rates have climbed from 46.9% since the late 1990s as medical care improved.

• Survival rate range: Outcomes reached 94.3% for patients diagnosed in recent years.
• European ranking: Lithuania ranks second in Europe for net survival after Cyprus.
• Early detection: Nationwide screening for men aged 50–69 began in 2006.
• Urban access: Patients in cities often see higher survival due to faster care.

Bookimed Expert Insight: High survival rates in Lithuania correlate with massive patient volumes at private centers. Medical Diagnostic and Treatment Center alone treats over 48,000 patients annually. This high repetition helps specialists maintain precision in complex robotic and NanoKnife procedures. International patients from the United Kingdom and Norway increasingly choose Vilnius for these outcomes.

Patient Consensus: Patients emphasize that early PSA screening leads to 90% survival for localized cases. Many note that choosing private clinics avoids long waits found in public systems.

Lithuania fully funds prostate cancer screening through the Early Prostate Cancer Detection Programme (EPCDP). The Compulsory Health Insurance Fund covers the cost for insured residents. This includes PSA blood tests, urologist consultations, and biopsies. Screening occurs every 2 to 5 years.

• Target age: Men aged 50 to 69 receive fully covered periodic screenings.
• High-risk groups: Coverage starts at age 45 for those with family history.
• Primary access: A general practitioner must prescribe the initial PSA blood test.
• Specialist care: Referral to a urologist is covered if PSA levels are elevated.

Bookimed Expert Insight: Private clinics like the Medical Diagnostic and Treatment Center in Vilnius handle over 48,000 patients annually. While the government covers basic screening, 10% of patients choose private centers to bypass waitlists. These facilities hold JCI and Temos accreditations, ensuring safety standards identical to Western Europe.

Patient Consensus: Patients note that while the PSA test is free, waitlists for follow-up MRIs can reach 6 months. Many suggest budgeting for private diagnostics to speed up the process if initial results show concerns.

Leading prostate cancer specialists in Lithuania include Dr. Paulius Bosas and Prof. Dr. Balys Dainys. These experts practice at major centers like Kardiolita Hospital and the Medical Diagnostic and Treatment Center. They specialize in laparoscopic surgery and advanced urological oncology for complex cases.

• Dr. Paulius Bosas: Performed over 1,500 laparoscopic and robotic prostate surgeries in Vilnius.
• Prof. Dr. Balys Dainys: Veteran urologist with over 30 years of clinical experience.
• Dr. Marius Kincis: Serves as the President of the Lithuanian Urological Society.
• Dr. Valerijus Ostapenko: Surgical oncologist with over 40 years of cancer treatment experience.

Bookimed Expert Insight: Clinical data shows a high concentration of expertise in Vilnius-based private centers. The Medical Diagnostic and Treatment Center serves over 48,000 patients annually. It holds both JCI and Temos International Healthcare accreditations. This combination of volume and certification is rare in the Baltic region. It suggests a high level of standardized safety for international patients.

Patient Consensus: Patients note that specialized care is centralized in Vilnius and Kaunas hospitals. They recommend having all PSA and biopsy results ready before meeting a specialist.

Lithuania offers high-quality prostate cancer care with a 94.3% 5-year survival rate. This matches Western European standards due to a unique national PSA screening program. Specialized centers in Vilnius provide advanced diagnostics and multidisciplinary treatment at costs significantly lower than in Germany or Austria.

• Early detection: Lithuania maintains the only systematic national PSA screening program in the world.
• Clinical expertise: Major centers like Medical Diagnostic and Treatment Center hold JCI and Temos accreditations.
• Surgical technology: Specialists perform robotic da Vinci prostatectomies, NanoKnife, and targeted hormone therapies.
• High volume: Local surgeons manage high patient loads, fostering expertise that rivals Western European clinics.

Bookimed Expert Insight: A major advantage in Lithuania is the concentration of expertise within a few high-volume private centers. Medical Diagnostic and Treatment Center in Vilnius employs 200 doctors and serves over 48,000 patients annually. While public system wait times can vary, private facilities offer rapid access to PSMA PET scans and robotic surgery. This combination of European Union safety standards and high procedural volume creates a high-value alternative to more expensive clinics in Scandinavia or the United Kingdom.

Patient Consensus: Patients note that robotic surgery in Lithuania costs roughly half as much as in other EU countries. They emphasize that outcomes, particularly regarding recovery speed and maintaining bladder control, are excellent when choosing high-volume surgeons.

Lithuania offers high-standard prostate cancer care with a 94.3% 5-year survival rate. Leading centres in Vilnius hold JCI and Temos International Healthcare accreditations. Surgeons perform robotic and laparoscopic prostatectomies. National screening programmes help maintain high early detection rates for all patients.

• Clinical safety: Medical Diagnostic and Treatment Center holds JCI and Temos International Healthcare accreditations.
• High survival: The 94.3% 5-year survival rate matches many Western European healthcare standards.
• Surgical volume: Major Vilnius facilities serve over 48,000 patients annually across 53 medical departments.
• Local expertise: Specialists in Kaunas and Vilnius focus on minimally invasive laparoscopic prostate removal.

Bookimed Expert Insight: Vilnius centres show a strong focus on Northern European patients. Approximately 10% of patients arrive from the United Kingdom, Ireland, and Sweden. This suggests clinicians are accustomed to English-speaking patients and international clinical protocols. This experience helps when coordinating complex cancer treatment plans across different countries.

Patient Consensus: Patients note the importance of confirming follow-up care with Australian GPs before travelling. Many suggest requesting specific diagnostic pathways and surgery timelines from the oncologist before arrival.

Lithuanian centres treat prostate cancer using robotic surgery, radiation, and non-invasive ultrasound. Specialists often use the da Vinci system for precise tumour removal. Patients also access intensity-modulated radiotherapy and hormone therapy. These techniques help preserve nerve function and speed up recovery times.

• Robotic surgery: Surgeons use da Vinci systems for minimally invasive prostate removal.
• Radiation therapy: Precise techniques like IMRT and brachytherapy target tumours accurately.
• HIFU technology: High-intensity focused ultrasound destroys cancer cells using heat.
• Systemic therapy: Hormone treatments and radioligand therapy manage advanced cancer stages.
• Early diagnostics: MRI-guided fusion biopsies provide high-precision detection for early-stage cases.

Bookimed Expert Insight: Lithuania offers a unique advantage for Australian patients seeking established private care. The Medical Diagnostic and Treatment Center in Vilnius serves 60,000 patients annually. It holds both JCI and Temos accreditations. This dual certification is rare and signals exceptional safety standards. Doctors here manage 53 different departments. This allows for the multidisciplinary care that prostate cancer requires.

Patient Consensus: Patients researching care in Lithuania focus on confirming if specialists use MRI-guided staging. They often note the importance of coordinating follow-up care with their Australian GP before travelling.

Plan prostate cancer treatment in Lithuania by choosing a JCI-accredited facility in Vilnius. Patients should arrange a 14-day stay for diagnostics and initial recovery. Carrying digital imaging and pathology reports is essential. Choosing clinics with international departments helps manage appointments and translation during specialist reviews.

• Accredited choice: Medical Diagnostic and Treatment Center in Vilnius holds JCI and Temos International accreditation.
• Clinical capacity: This facility features 53 departments and treats approximately 48,000 patients every year.
• International experience: About 10% of patients come from abroad, mainly from Sweden, Norway, and England.
• Stay duration: Build in extra days for pre-surgical imaging and bloodwork. This allows for post-operative monitoring before flying.

Bookimed Expert Insight: Clinics in Vilnius like the Medical Diagnostic and Treatment Center are multidisciplinary hubs. Having 53 departments in one place is a major advantage for patients. This setup allows for immediate cardiology or rehabilitation consultations without travelling to separate clinics. This integration can significantly speed up the pre-surgical clearance process.

Patient Consensus: Patients find it helps to arrange follow-up PSA monitoring with their local GP before leaving Australia. Carrying digital copies of biopsy results and pathology reports simplifies the admission process in Lithuania.

Lithuanian urologists are highly experienced in treating international patients. Major centres in cities like Vilnius serve thousands of patients annually. Many specialists are members of the EAU (European Association of Urology). They offer prostate cancer treatments including robotic da Vinci surgery and HIFU technology.

• Clinic volume: The Medical Diagnostic and Treatment Center treats 60,000 patients annually.
• Patient mix: Approximately 10% of patients travel from abroad for specialist medical care.
• Accreditations: Leading facilities hold Joint Commission International (JCI) and Temos International Healthcare accreditation.
• Treatment options: Specialists provide robotic surgery, hormone therapy, and high-intensity focused ultrasound (HIFU).

Bookimed Expert Insight: Lithuania stands out for treating patients from the UK, Ireland, and Scandinavia. Medical Diagnostic and Treatment Center in Vilnius reports that 1 in 10 patients is international. This consistent flow helps surgeons stay proficient in managing cross-border cases and English-language consultations. The clinic includes 200 doctors across 53 departments to support complex recoveries.

Patient Consensus: Patients recommend checking how clinics handle English-language communication and pathology reviews before flying. Many suggest coordinating with your Australian GP to manage follow-up care after returning home.

Patients should discuss their Gleason score and cancer stage to determine if treatment is curative. Specialists in Lithuania often manage complex cases. This is especially true at JCI-accredited centres like Medical Diagnostic and Treatment Center. Confirm whether surgery, radiotherapy, or active surveillance best suits the specific risk profile.

• Diagnosis details: Confirm Gleason score, PSA levels, and if the cancer is localised.
• Treatment goals: Ask if the primary objective is curative or long-term control.
• Functional recovery: Discuss risks of incontinence or erectile dysfunction and available rehabilitation.
• International follow-up: Arrange English-language discharge summaries for your Australian GP and urologist.

Bookimed Expert Insight: Lithuania's private system meets Northern European standards. Medical Diagnostic and Treatment Center in Vilnius serves 60,000 patients annually. One in 10 patients is international. This high volume means surgeons often have sharper skills in nerve-sparing techniques. Australian patients should check if their package includes post-operative rehabilitation programmes. These programmes can speed up the return to normal activities.

Patient Consensus: Patients in Lithuania find it vital to bring full imaging records from home. Most recommend confirming the fly-home date and ensuring English-speaking staff handle the discharge. Many suggest discussing remote PSA monitoring with their local urologist before travelling abroad.

Active surveillance in Lithuania involves structured monitoring with PSA tests every 4–6 months and annual MRI scans. Specialists at JCI-accredited centres like Medical Diagnostic and Treatment Centre manage this process. They evaluate pathology reports and imaging to check that the cancer remains non-aggressive.

• Specialist consultation: Urologists review prior medical records, PSA history, and biopsy pathology.
• Monitoring frequency: Patients typically undergo PSA testing twice yearly plus periodic MRI scans.
• Diagnostic review: Repeat biopsies occur every 12–36 months to track cellular changes.
• Accredited facilities: Major centres hold international certifications, including JCI and Temos International.

Bookimed Expert Insight: Clinical data shows 1 in 10 patients at leading Vilnius clinics travel from abroad. These facilities frequently coordinate with home-country GPs to manage long-term PSA tracking. This helps Australian patients maintain their monitoring schedule without staying in Lithuania for months.

Patient Consensus: Visitors highlight that bringing previous MRI discs and biopsy summaries prevents redundant testing in Lithuania. Patients also value receiving a written follow-up plan that specifies exactly when to start active treatment.